“…The serum biosignature consisting of 16 proteins (APRIL/TNFSF13, sCD30/TNFRSF8, chitinase 3-like 1, sIL-6Rα, IL-8, IL-11, IL-12(p70), IL-19, IL-28A/IFN-λ2, LIGHT/TNFSF14, MMP-1, MMP-2, MMP-3, OPN, PTX-3, TWEAK/TNFSF12) was found informative for the differentiation between the TB and HC groups, while the panel of 15 proteins (IL-6, APRIL/TNFSF13, sCD30/TNFRSF8, gp130/sIL-6β, IL-2, sIL-6Rα, IL-8, IL-29/IFNλ1, IL-35, MMP-2, MMP-3, OPN, PTX-3, sTNF-R2, TWEAK/TNFSF12) distinguished the HC group from the LTBI cohort. Currently, a number of studies have demonstrated a potential of blood-derived host protein biomarkers in the diagnosis of active TB [ 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 ]. A 6-marker serum protein biosignature consisting of CRP (c-reactive protein), IFN-γ, IP-10 (human interferon-inducible protein 10), CFH (complement factor H), Apo-AI (apolipoprotein AI), and SAA (serum amyloid A) showed a potential in the diagnosis of childhood tuberculous meningitis48.…”